Items Tagged ‘research’

March 28th, 2016

Dose-Dense Chemotherapy for Premenopausal Breast Cancer Improves Survival

By

Premenopausal women who have been diagnosed with breast cancer have improved survival if their chemotherapy doses are delivered every two weeks, compared to every three weeks. These results were recently presented at the 2016 European Breast Cancer Conference (EBCC-10) in the Netherlands. Chemotherapy following surgery is a standard treatment option for premenopausal women diagnosed with […]

View full entry

Tags: Breast Cancer, clinical trials, dose-dense, Metastatic Breast Cancer, News, premenopausal, research, Stage I Node Negative Breast Cancer, Stages II-III Breast Cancer


March 21st, 2016

Long-Term Survival of Childhood Cancer Survivors Continues to Improve

By

Among childhood cancer survivors, long-term survival continues to improve as treatment has been modified to reduce life-threatening, long-term side effects. These results were recently published in the New England Journal of Medicine. Among children diagnosed with cancer in the 70s and 80s, nearly 20% of those who survived for 5 years following diagnosis died within […]

View full entry

Tags: All Cancer Types, childhood cancer, long-term survival, News, research, survivors


February 10th, 2016

Year in Review: Myeloproliferative Neoplasms

By

Individuals dealing with myeloproliferative neoplasms (MPNs), including polycythemia vera (PV), essential thrombocythemia (ET) and myelofibrosis, typically experience difficult symptoms, life-threatening complications, and are at risk of progression to acute leukemia. The development and approval of the JAK2 inhibitor Jakafi® (Ruxolitinib) has led to more effective management of these symptoms in many patients with PV, positively […]

View full entry

Tags: essential thrombocythemia, jakafi, mpn, myelofibrosis, Myeloproliferative Neoplasms MPN, News, polycythemia vera, research, review


March 25th, 2015

Pacritinib May Be Effective against Myelofibrosis without Risk of Myelosuppression

By

The investigational agent pacritinib appears active against myelofibrosis without the risk of myelosuppression, a common side effect of many drugs used to treat myelofibrosis and other myeloproliferative neoplasms (MPN). The developers of pacritinib, CTI BioPharma Corp and Baxter International Inc, announced these findings from a Phase III clinical trial called PERSIST-1. Myelofibrosis is a type […]

View full entry

Tags: blood cancer, mpn, myelofibrosis, myeloproliferative neoplasms, Myeloproliferative Neoplasms MPN, News, pacritinib, PERSIST-1, research


November 11th, 2014

AFCR Scientists Uncovered Potential New Treatment for Ovarian Cancer

By

(CancerConnect) A potential new treatment for ovarian cancer – the most lethal cancer of the female reproductive system – has recently been uncovered, thanks to research supported in part by the Asian Fund for Cancer Research (AFCR). AFCR-funded scientist Wei Zhang, Ph.D., Professor at MD Anderson Cancer Center in the U.S. and Adjunct Professor at […]

View full entry

Tags: News, Ovarian Cancer, Recurrent Ovarian Cancer, research